Hazardous use of dissociative drugs including ketamine or PCP (Q50802): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Um padrão de uso de drogas dissociativas, incluindo quetamina e fenciclidina (PCP), que aumenta consideravelmente o risco de consequências nocivas a saúde física ou mental para o usuário ou para outras pessoas, numa medida que merece atenção e aconselhamento por profissionais de saúde. O risco aumentado pode decorrer da frequência de uso de drogas dissociativas, incluindo quetamina e PCP, da quantidade usada em determinada ocasião, de comportamentos de risco associados com o uso de drogas dissociativas, incluindo quetamina e PCP, ou com o contexto de uso, de uma via de administração insegura ou de uma combinação desses fatores. O risco pode estar relacionado com os efeitos de curto prazo das drogas dissociativas, incluindo quetamina e PCP, ou com os efeitos cumulativos de longo prazo sobre a saúde, física ou mental, ou a funcionalidade. O uso perigoso de drogas dissociativas, incluindo quetamina e PCP, ainda não foi suficiente para ter causado danos a saúde física ou mental do usuário ou de outras pessoas em seu redor. O padrão de uso de drogas dissociativas, incluindo quetamina e PCP, frequentemente persiste apesar da conscientização do aumento do risco de danos ao usuário ou a outras pessoas. | |||
| description / en | description / en | ||
A pattern of use of dissociative drugs including ketamine and PCP (phencyclidine) that appreciably increases the risk of harmful physical or mental health consequences to the user or to others to an extent that warrants attention and advice from health professionals. The increased risk may be from the frequency of use of dissociative drugs including ketamine and PCP, from the amount used on a given occasion, from risky behaviours associated with use of dissociative drugs including ketamine and PCP or the context of use, from a harmful route of administration, or from a combination of these. The risk may be related to short-term effects of dissociative drugs including ketamine and PCP or to longer-term cumulative effects on physical or mental health or functioning. Hazardous use of dissociative drugs including ketamine and PCP has not yet reached the level of having caused harm to physical or mental health of the user or others around the user. The pattern of use of dissociative drugs including ketamine and PCP often persists in spite of awareness of increased risk of harm to the user or to others. | |||
Revision as of 21:45, 13 August 2026
A pattern of use of dissociative drugs including ketamine and PCP (phencyclidine) that appreciably increases the risk of harmful physical or mental health consequences to the user or to others to an extent that warrants attention and advice from health professionals. The increased risk may be from the frequency of use of dissociative drugs including ketamine and PCP, from the amount used on a given occasion, from risky behaviours associated with use of dissociative drugs including ketamine and PCP or the context of use, from a harmful route of administration, or from a combination of these. The risk may be related to short-term effects of dissociative drugs including ketamine and PCP or to longer-term cumulative effects on physical or mental health or functioning. Hazardous use of dissociative drugs including ketamine and PCP has not yet reached the level of having caused harm to physical or mental health of the user or others around the user. The pattern of use of dissociative drugs including ketamine and PCP often persists in spite of awareness of increased risk of harm to the user or to others.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | QE11.7 |
||
| English | Hazardous use of dissociative drugs including ketamine or PCP |
A pattern of use of dissociative drugs including ketamine and PCP (phencyclidine) that appreciably increases the risk of harmful physical or mental health consequences to the user or to others to an extent that warrants attention and advice from health professionals. The increased risk may be from the frequency of use of dissociative drugs including ketamine and PCP, from the amount used on a given occasion, from risky behaviours associated with use of dissociative drugs including ketamine and PCP or the context of use, from a harmful route of administration, or from a combination of these. The risk may be related to short-term effects of dissociative drugs including ketamine and PCP or to longer-term cumulative effects on physical or mental health or functioning. Hazardous use of dissociative drugs including ketamine and PCP has not yet reached the level of having caused harm to physical or mental health of the user or others around the user. The pattern of use of dissociative drugs including ketamine and PCP often persists in spite of awareness of increased risk of harm to the user or to others. |
